Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Resmed Inc. sell Wolfe Research

Start price
€218.20
18.09.24 / 50%
Target price
€161.78
18.09.25
Performance (%)
-0.28%
Price
€217.60
22:26
Summary
This prediction is currently active. Since the start of the prediction for Resmed Inc. the price has only changed by -0.28%. This prediction currently runs until 18.09.25. The prediction end date can be changed by Wolfe_Research at any time. Wolfe_Research has 50% into this prediction
Performance without dividends (%)
Name 1w
Resmed Inc. -0.28%
iShares Core DAX® 1.510%
iShares Nasdaq 100 -0.271%
iShares Nikkei 225® -0.108%
iShares S&P 500 0.479%

Comments by Wolfe_Research for this prediction

In the thread Resmed Inc. diskutieren
Prediction Sell
Perf. (%) -0.28%
Target price 161.784
Change
Ends at 18.09.25

ResMed Inc. (NYSE: RMD) had its "underperform" rating re-affirmed by analysts at Wolfe Research. They now have a $180.00 price target on the stock.
Ratings data for RMD provided by MarketBeat